mRNA therapeutics for inflammatory bone diseases: opportunity and challenge
- 21 March 2026
- journal article
- review article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 695, 126793
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82370948)
- National Natural Science Foundation of China (82170941)
- Wuhan University
This publication has 112 references indexed in Scilit:
- Dendrimers Improve Apolipoprotein Nanoparticle mRNA Delivery to Immune CellsAdvanced Materials, 2025
- Engineered Biomimetic Nanovesicles Derived From Bone Marrow Stromal Cells With Innate Homing Capability for Targeted DeliveryAdvanced Materials, 2025
- Boosting mRNA‐Engineered Monocytes via Prodrug‐Like Microspheres for Bone Microenvironment Multi‐Phase Remodeling (Adv. Healthcare Mater. 7/2025)Advanced Healthcare Materials, 2025
- Ginsenoside Rd‐Loaded Antioxidant Polymersomes to Regulate Mitochondrial Homeostasis for Bone Defect Healing in PeriodontitisAdvanced Healthcare Materials, 2024
- Targeted Therapy of Osteoarthritis via Intra‐Articular Delivery of Lipid‐Nanoparticle‐Encapsulated Recombinant Human FGF18 mRNAAdvanced Healthcare Materials, 2024
- Innovative utilization of cell membrane‐coated nanoparticles in precision cancer therapyExploration, 2024
- Building a Better Silver Bullet: Current Status and Perspectives of Non‐Viral Vectors for mRNA VaccinesAdvanced Healthcare Materials, 2023
- Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer TherapyAdvanced Materials, 2023
- Global, regional, and national burden of periodontitis from 1990 to 2019: Results from the Global Burden of Disease study 2019Journal of Periodontology, 2022
- Arginine‐Rich Peptide‐Based mRNA Nanocomplexes Efficiently Instigate Cytotoxic T Cell Immunity Dependent on the Amphipathic Organization of the PeptideAdvanced Healthcare Materials, 2017